Phase None Active, not recruiting NCT05138263

Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's disease2

Seoul National University Hospital · Observational · n=640

22 views

Rate this page

★ ★ ★ ★ ★

Alzheimer's Disease

Study context: no flags matched. Amendment history is not available for this trial's data source.

Overview

The KBASE2 is the second phase of the KBASE project, which consists of roll-over participants from the first phase of the KBASE as well as newly enrolled participants with varying degrees of cognitive functions (e.g. individuals with normal cognition, mild cognitive impairment, or AD dementia). In addition to the aims of the first phase of the KBASE, the KBASE2 will focus on new data collection and integrative analysis of the rich structural, functional, and molecular neuroimaging data in relation to whole genome sequencing and other -omics. Network analysis of disruption in brain connectivity in relation to clinical status and AD biomarker profiles also will be conducted.

Full record on ClinicalTrials.gov (NCT ID NCT05138263).

Recruitment criteria

Age range: 20–90 · Sex: All · Healthy volunteers: Accepts

Study design

Phase: Phase None
Study type: Observational
Enrollment target: 640 participants
Started: January 2022
Estimated completion: September 2027

Outcome measures

Locations & contacts

Showing 2 of 2 sites

2 sites currently enrolling. Representative sites shown below; full site list on ClinicalTrials.gov.

SMG-SNU Boramae Medical Center — Seoul, Seoul (South Korea)

Seoul National University Hospital — Seoul (South Korea)

Sources

REG

ClinicalTrials.gov — NCT05138263

Trial registry · primary record